Clinical Trials on Breast Adenocarcinoma in Russian Federation

Total 427 results

Eli Lilly and Company

Completed

Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer

Breast Cancer | Neoplasm Metastasis

Russian Federation
Russian Academy of Medical Sciences

Completed

BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy

Early Triple Negative Breast Cancer

Russian Federation
Russian Academy of Medical Sciences

Completed

Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer

Triple Negative Breast Cancer

Russian Federation
Center of Personalized Medicine, Pirogova
I.M. Sechenov First Moscow State Medical University; Center for New Medical...

Unknown

Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer

Breast Cancer-specific Survival

Russian Federation
Tomsk National Research Medical Center of the Russian...

Recruiting

Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3

Primary Breast Cancer

Russian Federation
Tomsk National Research Medical Center of the Russian...
Uppsala University

Completed

99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast Cancer With Metastatic Lymph Nodes Before Targeted Therapy

Breast Cancer Female

Russian Federation
Tomsk National Research Medical Center of the Russian...

Enrolling by invitation

Molecular Imaging of HER2 Expression in Breast Cancer Using [99mTc]Tc-G3-(G3S)3C Before Chemo/Targeted Therapy

Breast Cancer Female

Russian Federation
Tomsk National Research Medical Center of the Russian...

Completed

Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ZHER2.

Breast Cancer Female

Russian Federation
Tomsk National Research Medical Center of the Russian...
Uppsala University; Institute of Bioorganic Chemistry, Russian Academy of Sciences

Completed

Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3 (HE3-G3)

Primary Breast Cancer

Russian Federation
Tomsk National Research Medical Center of the Russian...
Uppsala University

Completed

Molecular Imaging of HER2 Expression in HER2-positive Breast Cancer Using 99mTc-ADAPT6 vs 99mTc-DARPinG3

Breast Cancer Female

Russian Federation
Tomsk National Research Medical Center of the Russian...
Uppsala University

Completed

99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted Therapy

Female | HER2-positive Breast Cancer

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

Breast Cancer Stage IV

Russian Federation
Tomsk National Research Medical Center of the Russian...
Uppsala University; KTH Royal Institute of Technology

Completed

99mTc-ADAPT6-based HER2 Imaging in Breast Cancer (99mTc-ADAPT6)

Breast Cancer

Russian Federation
ARNA Genomics US Inc.
BIOMARKER-RU

Recruiting

Retrospective Comparative in Vitro Case-controlled Study of the Liquid Biopsy Test System in Women With Breast Cancer

Breast Neoplasm Female

Russian Federation
Tomsk National Research Medical Center of the Russian...
Uppsala University

Completed

99mTc-ADAPT6 SPECT-based Non-invasive Quantification of HER2-expression in Breast Cancer With Metastatic Lymph Nodes (99mTc-ADAPT6)

Breast Cancer | Female

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia (NEMO)

Breast Cancer | Neoadjuvant Endocrine Therapy

Russian Federation
Tatarstan Cancer Center

Unknown

Study Estimating Association Between Germline Mutations and PD-L1 Expression in Breast Cancer

Hereditary Breast Cancer

Russian Federation
Blokhin's Russian Cancer Research Center
Russian Society of Clinical Oncology

Completed

Abemaciclib for the Treatment of Luminal Metastatic breAst caNcer in the Real-life Clinical pracTice in Russia. (ATLANT)

Metastatic Disease | HR+/HER2- Breast Cancer | Аdvanced Disease

Russian Federation
Achieve Life Sciences

Completed

Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma

Colorectal Adenocarcinoma

Russian Federation
N.N. Petrov National Medical Research Center of...

Recruiting

Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer

Oligometastatic Disease | HER2-positive Metastatic Breast Cancer

Russian Federation
N.N. Petrov National Medical Research Center of...

Unknown

Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer

Breast Cancer

Russian Federation
N.N. Petrov National Medical Research Center of...

Unknown

Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer. (MBC1)

Breast Cancer

Russian Federation
Biocad

Completed

Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer

Breast Cancer

Russian Federation
Tomsk National Research Medical Center of the Russian...
Uppsala University

Completed

Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26

Prostate Cancer | Breast Cancer Female

Russian Federation
N.N. Petrov National Medical Research Center of...

Recruiting

Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB) (VAB)

Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNB

Russian Federation
KARANAHAN

Recruiting

Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide

Stage IV Breast Cancer

Russian Federation
Moscow Clinical Scientific Center
Negovsky Reanimatology Research Institute

Recruiting

The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial. (TeMP)

Breast Cancer | Anesthesia

Russian Federation
Eli Lilly and Company

Completed

Combination Chemotherapy for Metastatic Breast Cancer

Breast Cancer

Germany, Russian Federation
Antisoma Research

Terminated

Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer

Breast Carcinoma

Russian Federation
Tomsk National Research Medical Center of the Russian...
Uppsala University

Recruiting

Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8

Breast Cancer | Prostate Cancer

Russian Federation
Saint Petersburg State University, Russia

Not yet recruiting

A Prospective Single-center Cohort Study "Preoperative Identification of Sentinel Lymph Nodes Using Contrast-enhanced CT Lymphography in Breast Cancer Patients"

Breast Neoplasms | Sentinel Lymph Node

Russian Federation
S.LAB (SOLOWAYS)
Center of New Medical Technologies

Not yet recruiting

Clinical Trial Protocol: Randomized Placebo-Controlled Pilot Study of GcMAF (Soloways TM) in Patients With Metastatic Breast Cancer

Breast Cancer

Russian Federation
Alpha Tau Medical LTD.

Terminated

Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases

Metastatic Breast Cancer | Breast Carcinoma | Invasive Breast Cancer | Distant Metastases.Pathology

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III) (IRIGA)

Gastric Carcinoma Stage IV | Esophagogastric Junction Adenocarcinoma Stage IV

Russian Federation
Biocad

Recruiting

Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy of HER2-Positive Breast Cancer (PREFER)

Breast Cancer

Russian Federation
I.M. Sechenov First Moscow State Medical University

Recruiting

Non-contrast Magnetic Resonance Angiography in Deep Inferior Epigastric Perforator Flap Breast Reconstruction Planning

Breast Cancer | Postsurgical Acquired Absence of Organ

Russian Federation
Biocad

Active, not recruiting

A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of a Single Intravenous Infusion of BCD-178 or Perjeta® in Healthy Volunteers

Breast Cancer

Russian Federation
Moscow Clinical Scientific Center

Recruiting

A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations (Def_Special)

Breast Cancer | Solid Tumor | Gastrointestinal Cancer | Gynecological Malignancies | High-Risk Cancer | Myelosuppression

Russian Federation
Immanuel Kant Baltic Federal University
Center of Endourology "Endocenter"

Recruiting

Factors Affecting the Results of Treatment of Patients With Colorectal Cancer

Colorectal Cancer | Rectal Cancer | Colon Cancer | Colorectal Adenocarcinoma | Rectal Adenocarcinoma | Colorectal Neoplasms Malignant

Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

Prospective Comparison of the Four Biopsy Methods for Prostate Cancer Detection

Prostate Cancer | Prostate Adenocarcinoma

Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

Efficacy and Safety Assessment of IRE of Localized Prostate Cancer.

Prostate Cancer | Prostate Adenocarcinoma

Russian Federation
I.M. Sechenov First Moscow State Medical University
Pirogov Russian National Research Medical University; Moscow Regional Research...

Recruiting

Active Surveillance for Low Risk Prostate Cancer

Prostate Cancer | Prostate Adenocarcinoma

Russian Federation
I.M. Sechenov First Moscow State Medical University

Recruiting

Efficacy and Safety Assessment of IRE of Localized Prostate Cancer

Prostate Cancer | Prostate Adenocarcinoma

Russian Federation
Moscow Clinical Scientific Center

Recruiting

Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients

Breast Cancer | Pancreas Cancer

Russian Federation
Moscow City Oncology Hospital No. 62

Completed

[SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer (SENTRY)

Endometrial Neoplasms | Endometrial Cancer | Sentinel Lymph Node | Endometrial Endometrioid Adenocarcinoma | Endometrial Adenocarcinoma | Hysterectomy | Endometrial Cancer Stage I | Laparoscopic Hysterectomy | Endometrial Cancer Stage II

Russian Federation
Blokhin's Russian Cancer Research Center

Unknown

Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC) (EPITOC)

Ovarian Neoplasms | Ovarian Cancer | Chemotherapy | BRCA1 Mutation | BRCA2 Mutation | Serous Adenocarcinoma

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma (RusGCG-01)

Stomach Neoplasms | Gastrointestinal Neoplasms | Docetaxel | Oxaliplatin | Fluoruracil | Irinotecan Hydrochloride

Russian Federation
Meshalkin Research Institute of Pathology of Circulation

Completed

Effects of Anesthesia on Immunity in Cancer

Surgery | Renal Cancer

Russian Federation
Kidney Cancer Research Bureau

Completed

Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients

Carcinoma, Renal Cell

Russian Federation
I.M. Sechenov First Moscow State Medical University

Recruiting

The Evaluation of Functional Parenchymal Volume and Split Renal Function Before and After Partial Nephrectomy

Renal Cell Carcinoma

Russian Federation

Clinical Trials on Breast Adenocarcinoma in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations